Observational Study in Localized Osteosarcoma
ConditionLocalized Osteosarcoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 40
SponsorItalian Sarcoma Group
About this trial
Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by localized OsteoSarcoma (OS) treated according the AIEOP/Italian Sarcoma Group (ISG) OS 2021
Eligibility criteria
Qualifiers
Diagnosis of high grade OS of the extremities
Age at diagnosis ≤ 40 years at the time of diagnosis
Localized disease (skip metastases are allowed)
Adequate organ function according the AIEOP/ISG OS 2021 recommendation
Disqualifiers
Presence of metastases
Diagnosis of periosteal OS, of parosteal OS or secondary OS
Any medical condition which can not allowed the use of the treatments recommended by AIEOP/ISG OS 2021
Trial design
Treatments tested in this trial
- Treatment of Osteosarcoma according the AIEOP/ISG OS 2021 recommendations (includes drugs, surgery, radiotherapy or any other received treatments)
Treatment groups
120 Participants
are divided into 1 treatment groupSponsors and collaborators
Italian Sarcoma Group
Lead sponsor
Associazione Italiana Ematologia Oncologia Pediatrica
Collaborator
Source ClinicalTrials.gov